Evidence map›Paper›PMID 16952558›Full record

ArticleGastroenterology2006

Endogenous opioids inhibit early-stage pancreatic pain in a mouse model of pancreatic cancer.

Molly A Sevcik, Beth M Jonas, Theodore H Lindsay, Kyle G Halvorson, Joseph R Ghilardi, Michael A Kuskowski, Pinku Mukherjee, John E Maggio, Patrick W Mantyh

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Gastroenterology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Mechanisms of cancer pain.Frontiers in pain research (Lausanne, Switzerland) · 2022
    Review
  12. Article
  13. Article
  14. MicroRNA-330 Directs Downregulation of the GABAJournal of molecular neuroscience : MN · 2020
    Article
  15. Article
  16. Review
  17. The Study of Pain in Rats and Mice.Comparative medicine · 2019
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Molly A SevcikNeurosystems Center, Department of Diagnostic and Biological Sciences, University of Minnesota, Minneapolis, Minnesota 55455, USA.
Beth M Jonas
Theodore H Lindsay
Kyle G Halvorson
Joseph R Ghilardi
Michael A Kuskowski
Pinku Mukherjee
John E Maggio
Patrick W Mantyh
University of Minnesota · USUniversity of Minnesota Medical Center · USGeriatric Research Education and Clinical Center · USMayo Clinic in Arizona · USUniversity of Cincinnati · US

Funding

Peripheral Nociceptors in Persistent PainR01NS023970 · NINDS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MANTYH, PATRICK WILLIAM · 1987 to 2019
$3.7M
PERIPHERAL NOCICEPTORS IN PERSISTENT PAINR37NS023970 · NINDS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MANTYH, PATRICK WILLIAM · 2001 to 2007
$2.9M
Cancer Pain and Breast Tumor Metastasis to BoneR01NS048021 · NINDS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MANTYH, PATRICK WILLIAM · 2004 to 2007
$1.2M
NINDS NIH HHS NS048021NINDS NIH HHS NS23970NINDS NIH HHS R01 NS023970NINDS NIH HHS R01 NS048021NINDS NIH HHS R37 NS023970
6 · The paper itself

Abstract

BACKGROUND &

aimsThe endogenous opioid system is involved in modulating the experience of pain, the response to stress, and the action of analgesic therapies. Recent human imaging studies have shown a significant tonic modulation of visceral pain, raising the question of whether endogenous opioids tonically modulate the pain of visceral cancer.

methodsTransgenic mice expressing the first 127 amino acids of simian virus 40 large T antigen, under the control of the rat elastase-1 promoter, that spontaneously develop pancreatic cancer were used to investigate the role of endogenous opioids in the modulation of pancreatic cancer pain. Visceral pain behaviors were assessed as degree of hunching and vocalization.

resultsAlthough mice with late-stage pancreatic cancer displayed spontaneous, morphine-reversible, visceral pain-related behaviors such as hunching and vocalization, these behaviors were absent in mice with early-stage pancreatic cancer. After systemic administration of the central nervous system (CNS)-penetrant opioid receptor antagonists naloxone or naltrexone, mice with early-stage pancreatic cancer displayed significant visceral pain-related behaviors, whereas systemic administration of the CNS-nonpenetrant opioid antagonist naloxone-methiodide did not induce an increase in visceral pain behaviors.

conclusionsOur findings suggest that a CNS opioid-dependent mechanism tonically modulates early and late-stage pancreatic cancer pain. Understanding the mechanisms that mask this pain in early stage disease and drive this pain in late-stage disease may allow improved diagnosis, treatment, and care of patients with pancreatic cancer.

Indexed as

Abdominal PainAnimalsDisease Models, AnimalFemaleImmunohistochemistryMaleMiceNaloxoneNarcotic AntagonistsNeurotransmitter AgentsOpioid PeptidesPain MeasurementPancreatic NeoplasmsSeverity of Illness IndexTreatment OutcomeNaloxoneNarcotic AntagonistsNeurotransmitter AgentsOpioid Peptides

Identifiers

PMID16952558
PMCPMC2100397
OpenAlexW2119970606

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.